Assays News: Breaking Assays News, Comments and Articles.

Chromatrap® enriches epigenetic marks from primary cells

A new application note from Porvair Sciences details a protocol for its Chromatrap® ChIP assay kit that has been developed to enrich epigenetic marks from primary human tissue cells. Chromatrap® Pro-A, the novel solid-based matrix for chromatin immunoprecipitation assays (ChIP) has been successfully used for isolation of high quality chromatin from difficult biopsy material. Focusing on a...

G-Sphere Standards Go Viral

G-Sphere Standard for Molecular Norovirus Assays The G-Sphere range of Molecular Standards from Phthisis Diagnostics has expanded to include both parasites and viruses. Synthetic controls for Norovirus , both the common GI and GII genogroups, are now available in the UK, exclusively from Alpha Laboratories.G-Sphere controls provide stable, consistent, safe and abundant material for use...

CORRECTING and REPLACING Eureka Genomics Corp. Announces the Availability of a Human Sample Identification Service: EG-Human ID Barcode

First graph, second sentence of release should read: The test is now available as a testing service to ordering researchers and CRO’s, and will be available as a kit starting Q3 2013. (sted The test is now available as a testing service to ordering researchers and CRO’s, and will be available as a kit starting Q3 2014.). The corrected release...

Gram Scale Transient Antibody Production in CHO Cells with MaxCyte Electroporation

Dr. Hua Tu, CEO of LakePharma, and Dr. Peer Heine, Applications Scientist at MaxCyte, to Present Data Demonstrating Superior Performance and Scalability of MaxCyte Flow Electroporation in an Upcoming Webinar MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is hosting an educational webinar entitled “Large Scale...

Eureka Genomics Corp. Announces the Availability of a Human Sample Identification Service: EG-Human ID Barcode

Eureka Genomics (EG), a life science company providing innovative genetic analysis solutions, today announced the launch of an advanced new human identification service branded under the name EG-Human ID Barcode. The test is now available as a testing service to ordering researchers and CRO’s, and will be available as a kit starting Q3 2014. EGâ...

Salimetrics Redesigns Infant Swab for Faster, Easier Collection

A larger diameter infant swab with increased strength that will allow for greater fluid capacity is now available from Salimetrics. Salimetrics is offering its redesigned infant swab to make it easier to collect sufficient saliva volume for laboratory analysis. State College, PA (PRWEB) June 18, 2013 The new swab, designed for infants up to six months, produces increased fluid retention through t...

PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System

PathoGenetix has hired John A. Luckey, Ph.D., M.B.A., as Vice President of Engineering, to lead product development and system integration for the RESOLUTIONâ„¢ Microbial Genotyping System. The RESOLUTION System, which provides bacterial serotype and strain type information from complex mixtures in five hours, is currently in alpha testing, with beta testing of systems expected to commence in Q4 2...

LabCorp offers Roche's viral load assay for hepatitis C virus

Laboratory Corporation of America Holdings (LabCorp) has become the first clinical reference laboratory to offer Roche COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0, a viral load assay for hepatitis C virus.

Chembio's SURE CHECK(R) HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval

MEDFORD, N.Y., June 18, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care ("POC") diagnostic tests for infectious diseases, announced today that it's SURE CHECK® HIV 1/2 Assay has received CE Mark approval from European regulators. The SURE CHECK® HIV 1/2 Assay is now cleared for commercialization within the European Union (EU) for rapid, point-of-care d...

LabCorp provides viral load assay for Hepatitis C Virus in US

Laboratory Corporation of America Holdings (LabCorp) is offering the COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0, a quantitative viral load assay for Hepatitis C virus (HCV).

LabCorp Announces Availability of Newly Approved Viral Load Assay for Hepatitis C Virus

LabCorp becomes the First Major Clinical Reference Laboratory to Offer the Roche COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0 Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that it is offering the COBAS AmpliPrep/COBAS TaqMan HCV Test, v2.0. With enhanced sensitivity, this quantitative viral load assay for...

Repros, Exact Sciences planning follow-ons

Repros Therapeutics Inc. (NASDAQ:RPRX) and Exact Sciences Corp. (NASDAQ:EXAS) both announced plans late Monday to raise money in follow-ons. Repros proposed to sell up to 3 million shares in a follow-on underwritten by BofA Merrill Lynch; Lazard; Lad...

Any Assay, Any Wavelength, Any Bandwidth with the new CLARIOstar® high performance microplate reader

Over the years, many different assays have been designed...

Siemens to Create Companion Diagnostic Test for In-Development Janssen Heart Failure Drug

Today, Siemens Healthcare Diagnostics announces its entrance into a collaboration with Janssen Pharmaceutica NV to design, develop and commercialize a companion diagnostic test associated with an early-stage compound being developed by Janssen. This compound targets autoantibodies directed against the human β1-adrenergic receptor (β1-AR) that may contrib...

Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks

Xtalks presents an exciting live webinar on Friday June 27, 2013 at 11am EDT on the quantitative analysis of biomarkers with the specificity and robustness of liquid chromatography/mass spectrometry (LC/MS) and the sensitivity of ELISA. Toronto, Canada (PRWEB) June 17, 2013 As interest increases in developing novel biomarker and biotherapeutic assays to support clinical development, so does the n...

Aggravating Aggregators

Compound aggregation is a well-known problem in biochemical assays (although if you go back a few years, that certainly wasn't the case). Some small molecules will start to bunch up under some assay conditions, and instead of your target protein gett...

VistaGen Therapeutics Presents CardioSafe 3D(TM) and LiverSafe 3D(TM) Developments at International Society of Stem Cell Research's 11th Annual Meeting

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/17/13 -- VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism assays, presented key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in poster presentations at the 11th Annual Meeting of the International Society of Ste...

Practical Uses for Flow Cytometry in Toxicology Studies Within a Glp Environment, New Life Science Webinar Hosted by Xtalks

Xtalks presents an exciting live webinar on Tuesday, June 25, 2013 at 1:00 pm EDT on new advances in flow cytometry. Toronto, Canada (PRWEB) June 14, 2013 Flow cytometry is a valuable tool used to gain information pertinent to the immunotoxicity of pharmaceuticals. These assays can be integrated into preclinical toxicology studies and used on all standard toxicology species including mice, rats,...

Viral Outgrowth Assay Developed for Latent HIV

The development of a simpler assay for the latent reservoir of human immunodeficiency virus has been identified as a major...

Medicare Administrator Issues Final Local Coverage Determination for Rosetta Cancer Origin Testâ„¢

PHILADELPHIA and REHOVOT, Israel, June 13, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that Novitas Solutions, the designated Medicare Administrative Contractor (MAC) for the Company's microRNA-based diagnostic assays, has issued for notice the final revised Local Coverage Determination (LC...

Merck Millipore Adds Flow Cytometry Capabilities to Biomarker Testing Services

Merck Millipore, the Life Science division of Merck, today announced the expansion of its biomarker testing service capabilities with the launch of flow cytometry services at its North America facility. The service supports exploratory and GLP-requiring studies, and includes full and flexible assay development, validation and sample testing services using clinically established flow cyto...

Genomic assay as an alternative to animal testing

(Lund University) Earlier this spring, a ban on animal experiments for new cosmetics came into force in the EU. There is therefore a need to be able to determine whether a substance is allergenic without testing it on animals. Associate Professor Mal...

Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit

Eagle Biosciences expands their assay portfolio with the introduction of the highly sensitive and affordable Calprotectin ELISA Assay Kit. Nashua, NH (PRWEB) June 13, 2013 Eagle Biosciences is proud to announce the product launch of a brand new Calprotectin ELISA assay kit that offers the widest measurement range of any available assay (1-2000 µg/g stool). The Calprotectin ELISA assay kit is...

New fluorescent protein from eel revolutionizes key clinical assay

Many scientists dream of making a single discovery that provides fundamental insight into nature, may be used to help save human lives, and can assist in the preservation of an endangered species. In new research reported in the journal Cell, a Japan...

NanoString sets IPO range

Diagnostics company NanoString Technologies Inc. (Seattle, Wash.) amended its IPO and now plans to sell 5.4 million shares at $13-$15. At the $14 midpoint, NanoString would raise $75.6 million and be valued at $204.3 million. The company filed to rai...